AREXIS AB

AMENDISTA

Pharmaceutical preparations for the treatment of fat malabsorption; dietetic foods for medical purposes to treat fat malabsorption; infant formula;

CERLIANZA

Pharmaceutical preparations for the treatment of obesity; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, wound dressings, bandages for dressings, self adhesive dressings; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides; vaccines;

ECYFTRA

Pharmaceutical preparations for the treatment of skin diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical use; baby food; medical plasters; surgical dressings; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides; herbicides; vaccines;

ENZINAVIS

Pharmaceutical preparations for the treatment of glaucoma; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, wound dressings, bandages for dressings, self adhesive dressings; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides; vaccines;

EXINALDA

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF FAT MALABSORPTION; DIETETIC FOOD FOR MEDICAL PURPOSES TO TREAT FAT MALABSORPTION; INFANT FORMULA;

ITUDERON

Pharmaceutical preparations for the treatment of obesity; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; medical plasters; material for stopping teeth; materials for dressings, namely, bandages for dressings; burn dressings, surgical dressings; gauze for dressings; wound dressings; dental wax; disinfectants, namely, disinfectants for medical purposes and disinfectants for sanitary purposes; preparations for destroying vermin; fungicides; herbicides; vaccines;

KIOBRINA

Pharmaceutical and dietetic preparations for treatment of fat malabsorption; infant formula.;

KIVOLENZA

Pharmaceutical preparations, namely, tablets, capsules, liquids, inhalers, ointments, and lotions; veterinary preparations, namely, tablets, capsules, liquids, inhalers, ointments, and lotions; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; medical plasters; material for stopping teeth; materials for dressings, namely, bandages for dressings; burn dressings, surgical dressings; gauze for dressings; wound dressings; dental wax; disinfectants, namely, disinfectants for medical purposes and disinfectants for sanitary purposes; preparations for destroying vermin; fungicides; herbicides; vaccines;

LIFITUDE

Pharmaceutical preparations for the treatment of fat malabsorption; dietetic foods for medical purposes to treat fat malabsorption; infant formula;

SYNAGIS

humanized monoclonal antibody against respiratory syncytial virus for medical clinical use;[ humanized monoclonal antibody against respiratory syncytial virus for scientific research use ];

SYNAGIS CONNECT

Patient support program, namely, providing information about eligibility for financial assistance provided through patient benefits programs;

SYNAGIS CONNECT

The mark consists of the word SYNAGIS with three hand prints inside each other to the right of the word SYNAGIS with the word SYNAGIS and the three hand prints above the word CONNECT.;Patient support program, namely, providing information about eligibility for financial assistance provided through patient benefits programs;Color is not claimed as a feature of the mark.;